arrow
T

Takuya Tsunoda

Showa Medical University
H指数:39
被引数:4,476

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Association of Prior Local Therapy with Outcomes Within Systemic Therapy Regimen Cohorts in Advanced Soft Tissue Sarcoma: A Retrospective Cohort Study

先前局部治疗与系统性治疗方案队列中高级别软组织肉瘤预后的相关性:一项回顾性队列研究

Cancers
IF4.4
2026-08-290
OA
Comparing immunopathogenesis of non-human immunodeficiency virus immune reconstitution inflammatory syndrome and immune-related adverse events: A prospective multicenter cohort study

比较非人类免疫缺陷病毒免疫重建炎症综合征和免疫相关不良事件的免疫病理机制:一项前瞻性多中心队列研究

2025-03-290
PRE
Ki-67 expression in anti-programmed cell death protein-1 antibody-bound CD8+ T cells as a predictor of clinical benefit

Ki-67表达在程序性死亡蛋白-1抗体结合的CD8+ T细胞中作为临床获益的预测指标

2025-03-180
OA
Engineered Methioninase-expressing Tumor-targeting Salmonella typhimurium A1-R Inhibits Syngeneic-Cancer Mouse Models by Depleting Tumor Methionine

工程化甲硫氨酸酶表达、肿瘤靶向的Salmonella typhimurium A1-R通过耗竭肿瘤甲硫氨酸抑制同系癌症小鼠模型

2025-02-240
OA
Immune Stress-induced Tumor Mutation Burden and Neoantigen Expression in 4T1 Mammary Cancer Cells: A Potential Mechanism for Long-term Survival in Patients Treated With Immune Checkpoint Inhibitors

免疫应激诱导的肿瘤突变负荷及新抗原表达在4T1乳腺癌细胞中的作用:长期存活于接受免疫检查点抑制剂治疗患者的一种潜在机制

2024-12-270
OA
MHC class I polypeptide-related sequence B shedding modulates pancreatic tumor immunity via the activation of NKG2DLow T cells

MHC I类多肽相关序列B脱落通过激活NKG2DLow T细胞调节胰腺肿瘤免疫

2024-10-080
OAAI
Promotive clinical effects of pembrolizumab with necitumumab in patients having advanced non-small cell lung cancer with PD-L1 expression of 50% or higher in a phase II study (K-TAIL-202)
2024-04-050
PRE
Randomized phase I/II study of vascular endothelial growth factor receptor peptide vaccines for patients with hepatocellular carcinoma

肝细胞癌患者血管内皮生长因子受体多肽疫苗的随机I/II期研究

2023-12-270
PRE
Novel quantitative immunohistochemical analysis for evaluating PD-L1 expression with phosphor-integrated dots for predicting the efficacy of patients with cancer treated with immune checkpoint inhibitors

用荧光整合点评估PD-L1表达的新型定量免疫组织化学分析预测免疫检查点抑制剂治疗的癌症患者的疗效

2023-09-180
OAAI
Turicibacter and Acidaminococcus predict immune-related adverse events and efficacy of immune checkpoint inhibitor
2023-05-0322
OAAI